AN OPEN-LABEL, SINGLE-ARM, PHASE 1B STUDY TO EVALUATE THE EFFECT OF EMPASIPRUBART ON NERVE MORPHOLOGY BY ULTRASOUND IN ADULTS WITH MULTIFOCAL MOTOR NEUROPATHY
- Registry ID
- ARGX-117-8-MMN-1001
- Source registry
- HEALTH_CANADA
- Status
- Pending
- Phase
- PHASE1
- Study type
- INTERVENTIONAL
- Sponsor
- ARGENX BV
- Last update
- 2026-06-18
Conditions
- MULTIFOCAL MOTOR NEUROPATHY (MMN)
Related clinical trials
- A PHASE 3, RANDOMIZED, DOUBLE-BLINDED, DOUBLE-DUMMY STUDY EVALUATING THE
EFFICACY AND SAFETY OF EMPASIPRUBART VERSUS INTRAVENOUS IMMUNOGLOBULIN IN
ADULTS WITH MULTIFOCAL MOTOR NEUROPATHY
- A PHASE 2, RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED, STUDY TO EVALUATE
SAFETY, TOLERABILITY, PHARMACOMETRICS, AND EFFICACY OF DNTH103 IN ADULTS WITH
MULTIFOCAL MOTOR NEUROPATHY (MOMENTUM)
- A PHASE 2, RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTER TRIAL TO EVALUATE THE SAFETY AND TOLERABILITY, EFFICACY, PHARMACOKINETICS, PHARMACODYNAMICS, AND IMMUNOGENICITY OF 2 DOSE REGIMENS OF ARGX-117 IN ADULTS WITH MULTIFOCAL MOTOR NEUROPATHY
View on source registry